599
Views
525
CrossRef citations to date
0
Altmetric
Original Article

Rotavirus Disease in Finnish Children: Use of Numerical Scores for Clinical Severity of Diarrhoeal Episodes

&
Pages 259-267 | Published online: 08 Jul 2009

References

  • Butler TC. Viral diarrheas. J Diarrhoeal Dis Res 1984; 2: 137–141
  • Mäki M. A prospective clinical study of rotavirus diarrhoea in young children. Acta Paediatr Scand, 70: 107–113, 1981
  • Uhnoo I, Svensson L. Clinical and epidemiological features of acute infantile gastroenteritis associated with human rotavirus subgroups 1 and 2. J Clin Microbiol 1986; 23: 551–555
  • Gurwith M, Wenman W, Hinde D, Feltham S, Greenberg H. A prospective study of rotavirus infection in infants and young children. J Infect Dis 1981; 144: 218–224
  • Hjelt K, Grauballe PC, Palmegaard A, Nielsen OH, Krasilnikoff PA. Protective effect of pre-existing rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children. J Med Virol 1987; 21: 39–47
  • de Zoysa I, Feachem RG. Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization. Bull WHO 1985; 63: 569–583
  • Vesikari T. Progress in rotavirus vaccination. Pediatr Infect Dis 1985; 4: 612–614
  • Edelman R. Perspective on the development and deployment of rotavirus vaccines. Pediatr Infect Dis J 1987; 6: 704–710
  • Kapikian AZ, Flores J, Hoshino Y. Rotavirus: the major etiologic agent of severe infantile diarrhoea may be controllable by a “Jennerian” approach to vaccination. J Infect Dis 1986; 153: 815–822
  • Vesikari T, Isolauri E, Delem A, D'Hondt E, André FE, Zissis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus vaccine. Lancet 1984; 1: 977–981
  • Vesikari T, Isolauri E, Delem A, D'Hondt E, André FE, Beards GM, Flewett TH. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 1985; 107: 189–194
  • Vesikari T, Ruuska T, Delem A, André FE. Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine. A preliminary report. Pediatr Infect Dis J 1987; 6: 164–169
  • Clark HF, Borian FE, Bell LM, Modesto K, Gouvea V, Plotkin SA. Protective effect of WC 3 vaccine against rotavirus diarrhoea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988; 158: 570–586
  • Flores J, Perez-Schael I, Gonzales M, Carcilia D, Perez M, Daoud N, Cunto W, Chanock R, Kapikian AZ. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet 1987; 1: 882–884
  • Gothefors L, Wadell G, Juto P, Taniguchi K, Kapikian AZ, Glass R. Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J Infect Dis 1989; 159: 753–757
  • Ruuska T, Vesikari T, Delem A, André FE, Beards GM, Flewett TH. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: Correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period. Scand J Infect Dis 1990; 22: 269–278
  • Beards GM, Campbell AD, Cottrell NR, Peins J SM, Rees N, Sanders RC, Shirley JA, Wood HC, Flewett TH. Enzyme-linked immunosorbent assays based on polyclonal and monoclonal antibodies for rotavirus detection. J Clin Microbiol 1984; 19: 248–254
  • Beards GM. Serotyping of rotavirus by NADP-enhanced enzyme-immunoassay. J Virol Methods 1987; 18: 77–85
  • Delem A, Vesikari T. Determination of the serum antibody responses to the RIT 4237 rotavirus vaccine. J Med Virol 1987; 21: 231–238
  • Bishop R, Cipriani E, Lund JS, Barnes GL, Hosking CS. Estimation of rotavirus immunoglobulin and antibodies in human serum samples by enzyme-linked immunoadsorbent assay: Expression of results as units derived from a standard curve. J Clin Microbiol 1984; 19: 447–452
  • Ruuska T, Vesikari T, Grönroos P. A prospective study of acute diarrhoea in Finnish children from birth to 2 1/2 years of age: clinical severity, etiology and risk factors, Submitted for publication
  • Vesikari T, Isolauri E, André FE (1986) Protection of children for two years against rotavirus diarrhoea by RIT 4237 bovine (NCDV) rotavirus vaccine. Development of vaccines and drugs against diarrhoea, 11th Nobel Conference, Stockholm, 1985, J Holmgren, A Lindberg, R Möllby. Studentlicteratur, LundSweden, 185–191
  • Ho Mei-Shang, Glass RI, Pinsky PF, Anderson LJ. Rotavirus as a cause of diarrhoeal morbidity and mortality in the United States. J Infect Dis 1988; 158: 1112–1116

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.